Is It Time for a Thai Cancer Drug Fund? From Global Evidence to Collaborative Action – A Response to Recent Commentary
International Journal of Health Policy and Management · 22.07.2026 · 15 · 10127
DOI: 10.34172/ijhpm.10127 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Policy and Management, online erschienen am 22.07.2026. Verfasst von Parnnaphat Luksameesate und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Review of International Experience of a DedicatedFund to Support Patient Access to Cancer Drugs: Policy Implications for Thailand." 1 His highlights on balancing innovation, affordability, and equity provide an invaluable extension to our policy recommendations and open up crucial pathways for structural refinement. 2 Below, we address the specific methodological points raised and further contextualize the operational, social, and fiscal dimensions within Thailand's current healthcare landscape.
Zitieren
APA
Luksameesate, P., Nerapusee, O., Patikorn, C., & Anantachoti, P. (2026). Is It Time for a Thai Cancer Drug Fund? From Global Evidence to Collaborative Action – A Response to Recent Commentary. International Journal of Health Policy and Management, 15, 10127. https://doi.org/10.34172/ijhpm.10127
Vancouver
Luksameesate P, Nerapusee O, Patikorn C, Anantachoti P. Is It Time for a Thai Cancer Drug Fund? From Global Evidence to Collaborative Action – A Response to Recent Commentary. International Journal of Health Policy and Management. 2026;15:10127. doi:10.34172/ijhpm.10127
BibTeX
@article{Luksameesate2026,
author = {Luksameesate, Parnnaphat and Nerapusee, Osot and Patikorn, Chanthawat and Anantachoti, Puree},
title = {Is It Time for a Thai Cancer Drug Fund? From Global Evidence to Collaborative Action – A Response to Recent Commentary},
journal = {International Journal of Health Policy and Management},
year = {2026},
volume = {15},
pages = {10127},
doi = {10.34172/ijhpm.10127}
}
EUVIMED